Rho-kinase inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Rho-kinase inhibitor, covering 2024-07-30 to 2025-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL) [Phase 2]